相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression
J. Lade-Keller et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition
Liyun Miao et al.
MEDICAL ONCOLOGY (2013)
miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer
S-F Su et al.
ONCOGENE (2013)
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Brian E. Kadera et al.
PLOS ONE (2013)
Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell
Ning Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells
Remco van Horssen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis
Karmele Valencia et al.
CLINICAL CANCER RESEARCH (2012)
The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer
Ying Kong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis
Xiaobing Chen et al.
MOLECULAR BIOLOGY REPORTS (2012)
Involvement of discoidin domain 1 receptor in recurrence of hepatocellular carcinoma by genome-wide analysis
Zhi-Xiang Jian et al.
MEDICAL ONCOLOGY (2012)
Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
Wen Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Alterations of MicroRNAs Contribute to Colon Carcinogenesis
Aaron J. Schetter et al.
SEMINARS IN ONCOLOGY (2011)
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion
Qingli Shen et al.
MOLECULAR CANCER (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
The physiology and pathology of the EMT - Meeting on the epithelial-mesenchymal transition
Herve Acloque et al.
EMBO REPORTS (2008)
Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma
C. E. Ford et al.
BRITISH JOURNAL OF CANCER (2007)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Validation of the 2-ΔΔCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts
A Arocho et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2006)
TGF-β and epithelial-to-mesenchymal transitions
J Zavadil et al.
ONCOGENE (2005)
Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption
S Saadoun et al.
NATURE (2005)
Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition
M Maeda et al.
JOURNAL OF CELL SCIENCE (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines
JY Fang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation
EC Lai
NATURE GENETICS (2002)
Receptor tyrosine kinases as therapeutic targets: The model of the MET oncogene
P Longati et al.
CURRENT DRUG TARGETS (2001)